Prevention of Adolescent Major Depression

NCT00611052 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 65

Last updated 2016-04-20

No results posted yet for this study

Summary

The main purpose of this study is to assess the effect of a cognitive group intervention on prevention of major depression in 14-15-year-old adolescents. Moreover, the effect on other selected mental health parameters are investigated.

Conditions

  • Depressive Disorder

Interventions

BEHAVIORAL

the Adolescent Coping with Stress

A group cognitive intervention, manualized and highly structured. Includes 8 sessions (á 1.5 hours) and a booster session 6 months after termination of the actual intervention. Groups leaders are specifically trained for this course.

BEHAVIORAL

Treatment as usual

The usual treatment received by the adolescent with mild to moderate self-reported depressive symptoms in school health care.

OTHER

usual health education

usual health education given by the school nurses, targeted for healthy controls with no depressive symptoms according to the self-report scale

Sponsors & Collaborators

  • University of Helsinki

    collaborator OTHER
  • University of Eastern Finland

    collaborator OTHER
  • Kuopio University Hospital

    collaborator OTHER
  • City of Vantaa

    collaborator OTHER_GOV
  • City of Kuopio

    collaborator OTHER_GOV
  • City of Turku

    collaborator OTHER_GOV
  • Finnish Institute for Health and Welfare

    lead OTHER_GOV

Principal Investigators

  • Mauri J Marttunen, Professor · National Institute for Health nd Welfare, Dept of Mental Health and Substance Abuse Services

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
14 Years
Max Age
16 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-03-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00611052 on ClinicalTrials.gov